ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 32 (5) , 598-608
Abstract
No abstract availableKeywords
Funding Information
- VIVA-KKH Pediatric Brain and Solid Tumor Program
This publication has 38 references indexed in Scilit:
- Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 casesLaboratory Investigation, 2018
- Expanding the Phenotype of ALK-positive Histiocytosis: A Report of 2 CasesPediatric and Developmental Pathology, 2017
- ALKFusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted TherapyThe Oncologist, 2017
- Two Cases of Renal Cell Carcinoma Harboring a Novel STRN-ALK Fusion GeneAmerican Journal of Surgical Pathology, 2016
- Expanding the spectrum of ALK‐rearranged renal cell carcinomas in children: Identification of a novel HOOK1‐ALK fusion transcriptGenes, Chromosomes and Cancer, 2016
- Anaplastic Lymphoma Kinase–Positive Diffuse Large B-Cell Lymphoma: A Rare Clinicopathologic Entity With Poor PrognosisJournal of Clinical Oncology, 2009
- Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western PopulationClinical Cancer Research, 2009
- ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancyBlood, 2008
- Pediatric inflammatory myofibroblastic tumor: Anaplastic lymphoma kinase (ALK) expression and prognosisPediatric Blood & Cancer, 2004
- Systemic Form of Juvenile Xanthogranuloma: Report of a Case with Liver and Bone Marrow InvolvementPediatric and Developmental Pathology, 2004